CAL-T Constructs and Uses Thereof - Boston University Patent EP4093768A1
Summary
The EPO published patent application EP4093768A1 for CAL-T constructs filed by Trustees of Boston University and The General Hospital Corporation. The A1 publication includes a European search report and covers immunological constructs including antibodies against immune receptors (C07K 16/28) and therapeutic proteins (C07K 14/705, C07K 14/725). The patent is designated for all EU member states and several other European jurisdictions.
What changed
The EPO published patent application EP4093768A1 titled 'CAL-T Constructs and Uses Thereof' filed by Trustees of Boston University and The General Hospital Corporation. The patent covers CAL-T constructs (cell therapy constructs related to CAR-T technology) including antibodies against immune receptors (C07K 16/28) and therapeutic peptides/proteins (C07K 14/705, C07K 14/725, C07K 14/74). The A1 publication indicates a European search report has been issued.
For biotechnology and pharmaceutical companies developing cell therapy or immunological products, this patent publication establishes intellectual property rights in European markets. The designated states include all major EU economies (DE, FR, GB, IT, ES, NL, BE, AT, SE, DK, FI, PL) plus Switzerland, Norway, and Turkey. Competitors should assess freedom-to-operate for any overlapping product development in these jurisdictions.
What to do next
- Monitor for patent validation decisions in specific European countries
- Review if existing research programs may be affected by this patent coverage
- Track maintenance fees and national phase deadlines
Archived snapshot
Apr 10, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
CAL-T CONSTRUCTS AND USES THEREOF
Publication EP4093768A1 Kind: A1 Apr 01, 2026
Applicants
Trustees of Boston University, The General Hospital Corporation
Inventors
PAKYARI, Mohammadreza, CETRULO, Curtis, WONG, Wilson, OKUMA, Atsushi
IPC Classifications
C07K 16/28 20060101AFI20231009BHEP A61K 38/17 20060101ALI20231009BHEP C07K 14/705 20060101ALI20231009BHEP A61K 39/00 20060101ALI20231009BHEP A61K 38/00 20060101ALI20231009BHEP C07K 14/74 20060101ALI20231009BHEP C07K 14/725 20060101ALI20231009BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.